These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 10384156

  • 1. Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells.
    Tarte K, Zhang XG, Legouffe E, Hertog C, Mehtali M, Rossi JF, Klein B.
    J Immunol; 1999 Jul 01; 163(1):514-24. PubMed ID: 10384156
    [Abstract] [Full Text] [Related]

  • 2. B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro.
    Lu ZY, Condomines M, Tarte K, Nadal L, Delteil MC, Rossi JF, Ferrand C, Klein B.
    Exp Hematol; 2007 Mar 01; 35(3):443-53. PubMed ID: 17309825
    [Abstract] [Full Text] [Related]

  • 3. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
    Fenton RG, Turcovski-Corrales SM, Taub DD.
    J Immunother; 1998 Mar 01; 21(2):95-108. PubMed ID: 9551360
    [Abstract] [Full Text] [Related]

  • 4. Gene transfer of the costimulatory molecules B7-1 and B7-2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell response.
    Wendtner CM, Nolte A, Mangold E, Buhmann R, Maass G, Chiorini JA, Winnacker EL, Emmerich B, Kotin RM, Hallek M.
    Gene Ther; 1997 Jul 01; 4(7):726-35. PubMed ID: 9282174
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes.
    Sulé-Suso J, Arienti F, Melani C, Colombo MP, Parmiani G.
    Eur J Immunol; 1995 Oct 01; 25(10):2737-42. PubMed ID: 7589065
    [Abstract] [Full Text] [Related]

  • 7. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
    Qian J, Wang S, Yang J, Xie J, Lin P, Freeman ME, Yi Q.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8808-15. PubMed ID: 16361569
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD, Hermonat PL, Ravaggi A, Bellone S, Pecorelli S, Cannon MJ, Parham GP.
    Am J Obstet Gynecol; 2000 Sep 15; 183(3):601-9. PubMed ID: 10992180
    [Abstract] [Full Text] [Related]

  • 10. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.
    Chaux P, Luiten R, Demotte N, Vantomme V, Stroobant V, Traversari C, Russo V, Schultz E, Cornelis GR, Boon T, van der Bruggen P.
    J Immunol; 1999 Sep 01; 163(5):2928-36. PubMed ID: 10453041
    [Abstract] [Full Text] [Related]

  • 11. B7.1 costimulation increases T-cell proliferation and cytotoxicity via selective expansion of specific variable alpha and beta genes of the T-cell receptor.
    Chan AK, Goedegebuure PS, von Bernstorff W, Carritte AL, Chung M, Stewart RA, Montgomery L, Spanjaard RA, McKenzie AB, Eberlein TJ.
    Surgery; 2000 Mar 01; 127(3):342-50. PubMed ID: 10715992
    [Abstract] [Full Text] [Related]

  • 12. Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens.
    Kim SK, Nguyen Pham TN, Nguyen Hoang TM, Kang HK, Jin CJ, Nam JH, Chung SY, Choi SJ, Yang DH, Kim YK, Chung IJ, Kim HJ, Lee JJ.
    Ann Hematol; 2009 Nov 01; 88(11):1113-23. PubMed ID: 19277657
    [Abstract] [Full Text] [Related]

  • 13. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S, Wehler T, Schnürer E, Lennerz V, Brenner W, Melchior S, Gröne M, Nonn M, Strand S, Meyer R, Ranieri E, Huber C, Falk CS, Herr W.
    Cancer Res; 2006 Dec 01; 66(23):11447-54. PubMed ID: 17145892
    [Abstract] [Full Text] [Related]

  • 14. Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse.
    Schendel DJ, Frankenberger B, Jantzer P, Cayeux S, Nöbetaner E, Willimsky G, Maget B, Pohla H, Blankenstein T.
    Gene Ther; 2000 Dec 01; 7(23):2007-14. PubMed ID: 11175312
    [Abstract] [Full Text] [Related]

  • 15. Functional B7.2 and B7-H2 molecules on myeloma cells are associated with a growth advantage.
    Yamashita T, Tamura H, Satoh C, Shinya E, Takahashi H, Chen L, Kondo A, Tsuji T, Dan K, Ogata K.
    Clin Cancer Res; 2009 Feb 01; 15(3):770-7. PubMed ID: 19188146
    [Abstract] [Full Text] [Related]

  • 16. B7.1 on human carcinomas: costimulation of T cells and enhanced tumor-induced T-cell death.
    Lang S, Atarashi Y, Nishioka Y, Stanson J, Meidenbauer N, Whiteside TL.
    Cell Immunol; 2000 May 01; 201(2):132-43. PubMed ID: 10831322
    [Abstract] [Full Text] [Related]

  • 17. Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells.
    Yang S, Darrow TL, Seigler HF.
    Cancer Res; 1997 Apr 15; 57(8):1561-8. PubMed ID: 9108460
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules.
    Liu Y, Wang H, Zhao J, Ma J, Wei L, Wu S, Xie T, Shen F, Trojan J, Habib N, Anthony DD, Wu M, Guo Y.
    Cancer Gene Ther; 2000 Mar 15; 7(3):456-65. PubMed ID: 10766352
    [Abstract] [Full Text] [Related]

  • 19. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
    Huang H, Li F, Gordon JR, Xiang J.
    Cancer Res; 2002 Apr 01; 62(7):2043-51. PubMed ID: 11929823
    [Abstract] [Full Text] [Related]

  • 20. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.
    Tsang KY, Zhu M, Even J, Gulley J, Arlen P, Schlom J.
    Cancer Res; 2001 Oct 15; 61(20):7568-76. PubMed ID: 11606396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.